Related Experiment Video
Updated: Sep 27, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Tumor suppression by Ink4a-Arf: progress and puzzles
Scott W Lowe1, Charles J Sherr
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA. lowe@cshl.org
Abstract:
The two products of the Ink4a-Arf locus, p16(Ink4a) and p19(Arf) (p14(ARF) in humans), are potent tumor suppressors that regulate the activities of the retinoblastoma protein and the p53 transcription factor. These proteins form part of a signaling network that is disrupted in most, if not all, cancer cells. The Ink4a-Arf locus responds to stress signals, limiting cell proliferation and modulating oncogene-induced apoptosis. Recent evidence emerging from mouse tumor models distinguishes the activities of p16(Ink4a) and p19(Arf) in regulating tumor onset and identifies differences in their responsiveness to drugs.
Insights
The Ink4a-Arf locus produces tumor suppressors p16(Ink4a) and p19(Arf) (p14(ARF) in humans) that are crucial in cancer. Mouse models reveal distinct roles for these proteins in tumor development and drug response.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The Ink4a-Arf locus encodes two key tumor suppressors: p16(Ink4a) and p19(Arf) (p14(ARF) in humans).
- These proteins regulate critical cell cycle regulators, including the retinoblastoma protein and p53.
- Their signaling network is frequently dysregulated in various cancer types.
Purpose of the Study:
- To elucidate the distinct roles of p16(Ink4a) and p19(Arf) in tumor suppression.
- To investigate the differential responsiveness of these tumor suppressors to therapeutic agents.
Main Methods:
- Utilized mouse tumor models to study Ink4a-Arf locus products.
- Differentiated the functional activities of p16(Ink4a) and p19(Arf) in tumor onset.
- Assessed drug sensitivity associated with p16(Ink4a) and p19(Arf) activities.
Main Results:
- Mouse models demonstrated that p16(Ink4a) and p19(Arf) have separate functions in regulating tumor initiation.
- Differences in drug responsiveness were observed between p16(Ink4a) and p19(Arf) pathways.
- The Ink4a-Arf locus responds to cellular stress, impacting proliferation and apoptosis.
Conclusions:
- p16(Ink4a) and p19(Arf) possess distinct tumor suppressor activities.
- Targeting these pathways may offer differential therapeutic strategies in cancer treatment.
- Understanding the Ink4a-Arf network is vital for cancer therapy development.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

